The Medicines and Healthcare Products Regulatory Agency (MHRA) reported in late 2014 MHRA 2014 after reviewing literature generated from York report in 2012 and commissioning further literature review in 2012, taking submissions from support groups and reviewed adverse events reports made to MHRA, engaging with professional organisations, regulatory bodies in European Union and USA and participated in European Commision (EC) Task Force Group on vagina mesh implants. The full report was extensive and concluded on the data before them that: for the majority of women, the use of vaginal mesh implants is safe and effective the current evidence shows that when these products are used correctly they can help alleviate the very distressing symptoms of SUI and POP and as such the benefits still outweigh the risks